ID   HKCI-C3
AC   CVCL_SA03
DR   EGA; EGAD00001004475
DR   Wikidata; Q54889764
RX   PubMed=15645427;
RX   PubMed=15709204;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
RX   PubMed=15645427; DOI=10.1002/ijc.20684;
RA   Chan K.Y.-Y., Wong N., Lai P.B.-S., Squire J.A., Macgregor P.F.,
RA   Beheshti B., Albert M., To K.-F., Johnson P.J.;
RT   "Transcriptional profiling on chromosome 19p indicated frequent
RT   downregulation of ACP5 expression in hepatocellular carcinoma.";
RL   Int. J. Cancer 114:902-908(2005).
//
RX   PubMed=15709204; DOI=10.1158/1078-0432.1319.11.3;
RA   Wong N., Chan K.Y.-Y., Macgregor P.F., Lai P.B.-S., Squire J.A.,
RA   Beheshti B., Albert M., Leung T.W.-T.;
RT   "Transcriptional profiling identifies gene expression changes
RT   associated with IFN-alpha tolerance in hepatitis C-related
RT   hepatocellular carcinoma cells.";
RL   Clin. Cancer Res. 11:1319-1326(2005).
//